Product image of Larylin Husten-Stiller (Dropropizine) supplied by GNH India

Larylin Husten-Stiller

Active Ingredient:
Dropropizine
Origin:
EU

Larylin Husten-Stiller (Dropropizine)

Dropropizine, the active ingredient in Larylin Husten-Stiller, is an antitussive presented as an oral formulation for oral use. It suppresses dry, non‑productive coughs in adults and children by acting on peripheral cough receptors. The medication is available without a prescription across the European Union and is intended for short‑term relief of irritating coughs that do not produce mucus.

GNH India supplies Larylin Husten‑Stiller as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance for each batch delivered.

Manufacturer / TM Owner

Robugen Gmbh Pharmazeutische Fabrik

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Dropropizine acts as a peripheral antitussive to reduce the cough reflex in conditions characterized by dry or non‑productive cough.
  • Dry cough: provides symptomatic relief by decreasing cough frequency and intensity.
  • Non‑productive cough: eases throat irritation without promoting mucus production.
  • Cough due to throat irritation: reduces the urge to cough caused by mild inflammatory stimuli.

How It Works

  • Dropropizine exerts its antitussive effect by desensitizing peripheral cough receptors located in the respiratory mucosa. The compound interferes with the afferent limb of the cough reflex, reducing the transmission of irritant signals to the brainstem cough centre without affecting central nervous system activity. This peripheral action results in a decrease in cough frequency while preserving normal respiratory function.

Side Effects

Dropropizine is generally well tolerated, but several adverse reactions have been reported.

Common Side Effects

  • Nausea: mild stomach upset occurring shortly after ingestion.
  • Dizziness: transient light‑headedness, especially after the first dose.
  • Dry mouth: reduced salivation leading to a feeling of throat dryness.
  • Headache: mild to moderate headache not requiring medical intervention.

Serious or Rare Side Effects

  • Allergic skin reactions: rash, urticaria, or itching that may indicate hypersensitivity.
  • Anaphylactic shock: rare but severe systemic allergic response requiring immediate medical attention.

Precautions & Warnings

  • Before using Larylin Husten-Stiller, consider the following safety measures.
  • Pregnancy: consult a healthcare professional before use.
  • Breastfeeding: use with caution as safety data are limited.
  • Renal impairment: dose adjustment may be required.
  • Concomitant CNS depressants: monitor for enhanced sedation.
  • Children under 2 years: not recommended unless advised by a physician.
  • Store at below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Dropropizine may interact with other substances; review the following categories.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of additive central nervous system depression.
  • Strong CYP3A4 inhibitors: may increase dropropizine plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Alcohol: may enhance sedative effects.
  • Other antitussives: additive cough suppression may lead to excessive suppression.
  • Antihistamines: may increase dryness of mouth and throat.

Frequently Asked Questions

Larylin Husten-Stiller is an oral antitussive containing dropropizine, indicated for the symptomatic relief of dry, non‑productive coughs. It is used to reduce the frequency and intensity of coughing caused by throat irritation or mild respiratory irritation, providing short‑term comfort without promoting mucus production.

Dropropizine works as a peripheral antitussive. It desensitizes cough receptors in the respiratory mucosa, decreasing the transmission of irritant signals to the brainstem cough centre. By acting outside the central nervous system, it reduces cough reflex activity while preserving normal breathing function.

The appropriate dose of Larylin Husten-Stiller is determined by a qualified healthcare professional based on the patient’s age, weight, and clinical condition. Prescribers select the regimen that best balances efficacy and safety, and patients should follow the specific instructions provided on the prescription label.

Safety data for dropropizine in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Larylin Husten-Stiller.

To order Larylin Husten-Stiller, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The sales team will then respond with pricing, availability, shipping details and any necessary import documentation.

Compared with central‑acting cough suppressants such as codeine, dropropizine offers a peripheral mechanism of action, which generally results in fewer central nervous system side effects like drowsiness. It is available over the counter in the EU, whereas many opioid‑based suppressants require prescription and carry higher abuse potential.

Larylin Husten-Stiller should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Larylin Husten-Stiller is taken orally as directed by a healthcare professional. The tablet or liquid is swallowed with a glass of water, and dosing intervals are spaced according to the prescriber’s instructions, typically not exceeding the recommended daily maximum.

The most serious risks include allergic reactions such as rash, urticaria, or, in rare cases, anaphylactic shock. Patients should seek immediate medical attention if they experience swelling of the face, difficulty breathing, or any signs of a severe hypersensitivity reaction.

Larylin Husten-Stiller should be avoided in individuals with known hypersensitivity to dropropizine or any excipients, in children under two years of age unless specifically prescribed, and in patients taking contraindicated medications such as MAO inhibitors without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dropropizine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT